<DOC>
	<DOCNO>NCT02495038</DOCNO>
	<brief_summary>BACKGROUND : The combination rocuronium cisatracurium synergic effect . The investigator study whether prediction possible sufficient effect reduce dose combine two neuromuscular block agent monitor neuromuscular relaxation surgery . METHODS : Each group intubate dose group ( Group I , n=27 ) combine Effective Dose ( ED ) 95 rocuronium ED95 cisatracurium , small amount reduce group ( Group S , n=27 ) reduce 10 % ED95 large amount reduce group ( Group L , n=27 ) reduce 20 % ED95 . Before patient arrive operating room , rocuronium cisatracurium prepared nurse involve study . Each study drug administrate patient timer start TOF-Watch® monitoring . Train-of-four ( TOF ) ulnar nerve use set 2 Hz per 12 sec . The investigator check time TOF ratio=0 ( Onset ) , time 1st TOF ratio &gt; 25 % ( Duration 25 % ) TOF 25-75 % ( recovery index ) total i.v . anesthesia ( TIVA ) . One way ANOVA use statistical analysis ( α=0.05 , β=0.2 ) .</brief_summary>
	<brief_title>Optimal Dose Combination Rocuronium Cisatracurium</brief_title>
	<detailed_description>Introduction : Rocuronium cisatracurium representative neuromuscular blocking agent use widely former feature fast onset peak effect short duration muscle relaxation relatively latter comparatively long duration relaxation time break Hofmann elimination ester hydrolysis . A combination two synergic effect may also use either prim method rapid sequence intubation . It would contribute determine effective combination rate clinically predict pharmacokinetic characteristic determine much synergistic effect combination . The investigator study whether prediction possible sufficient effect reduce dose combine two muscle relaxant monitor muscle relaxation surgery . Materials method : This study conduct 81 patient schedule elective mastoidectomy tympanoplasty obtain write informed consent . All patient include American Society Anesthesiologists ( ASA ) physical status I-II , age 20-60 , BMI 20-30 kg/m2 . The exclusion criterion follow : history allergy study drug , neuromuscular disease , pregnancy breast-feeding , preoperative medication antipsychotic neuroleptic know interact non-depolarizing neuromuscular blocking agent ( NMBAs ) , serum creatinine level &gt; 1.2 mg/dL , liver transaminase &gt; 40 U/L . Anthropometric variable height , weight measure ward surgery . BMI calculate total body weight divide squared height . Ideal body weight ( IBW ) calculate formula Devine { 50 kg + 2.3 × ( height [ inch ] -60 ) man 45.5 kg + 2.3 × ( height [ inch ] -60 ) woman } use administrate NMBAs initial dose . Lean body weight ( LBW ) calculate formula James { LBW ( men ) = ( 1.10 × Weight ( kg ) ) - 128 × ( Weight2 / ( 100 × Height ( ) ) 2 ) , ( woman ) = ( 1.07 × Weight ( kg ) ) - 148 × ( Weight2 / ( 100 × Height ( ) ) 2 ) } . Additive dose NMBAs administrate LBW . Patients randomly assign group open seal allocation envelope . Each group intubate dose group ( Group I , n=27 ) combine ED95 rocuronium ED95 cisatracurium , small amount reduce group ( Group S , n=27 ) reduce 10 % ED95 large amount reduce group ( Group L , n=27 ) reduce 20 % ED95 . Monitoring Medication : In operating room , monitor accomplished patient noninvasive blood pressure , pulse oximetry , electrocardiography , thermometer , Bispectral Index ( BIS VISTA Monitoring System ; Aspect Medical Systems Inc , Norwood , MA , USA ) , T1/T4 ratio use TOF-Watch® ( Organon , Teknica B.V. , Boxtel , Netherlands ) . Every 5 min , measure thing record . Premedications midazolam 2 mg glycopyrrolate 0.2 mg administrate patient intramuscularly 1 h surgery . Before patient arrive operating room , rocuronium cisatracurium prepared nurse involve study . The syringe contain study drug convey performer study status shield scale . The syrinx rocuronium cisatracurium use syringe . Anesthesia induce propofol 1.5-2.5 mg/kg , remifentanil 0.4-0.6 mcg/kg , afterward maintain target control infusion ( TCI ) propofol 5-10 mg/kg/hr remifentanil 0.05-2 mcg/kg/min . The infusion pump ( Orchestra Module DPS , Fresenius-Vial , Brezins , France ) operate Minto 's Marshall 's pharmacokinetic model effect site TCI remifentanil propofol . The opposite arm operation side use neuromuscular monitoring attach armboard TOF-Watch® . Each study drug administrate patient timer start T1/T4 ratio monitoring . The surface electrodes ulnar nerve place wrist Train-of-four ( TOF ) stimulation use set supramaximal square wave impulses 200μs duration , 2 Hz per 12sec . The investigator check time TOF ratio=0 ( Onset ) , 1st TOF ratio &gt; 25 % ( Duration 25 % ) TOF 25-75 % ( Recovery Index ) , recovery time 90 % ( TOF 25-90 % ) total i.v . anesthesia ( TIVA ) . Also investigator check rate additional rescue dose administrate 10 % initial NMBAs dose , operation time incision surgical wound dressing , anesthesia time enter go operation room . Body temperature maintain 35°C use warm air blanket . The arterial pressure cuff place opposite arm TOF monitoring . Adverse Events Management : In patient , anesthesia level assess base BIS score 40-60 . Moderate hypertension ( &gt; 120 % baseline ) hypotension ( &lt; 80 % baseline ) treat increase decrease rate propofol infusion fluid supplement . Severe hemodynamic change ( systolic pressure &lt; 90 mmHg &gt; 200 mmHg ) control intravenous ( IV ) administration phenylephrine 50 mcg nicardipine 250 mcg repeatedly hemodynamic stable status . Unexpectedly , hiccup self-contained respiration show , additional rescue dose NMBAs administrate patient even though T1/T4 ratio low 25 % . Statistical Analysis : All data express mean ± standard deviation ( SDs ) , number ( percentage ) , median ( upper low quartile ) , appropriate . Data group compare use χ2 test , Fisher exact test , independent test , Mann-Whitney U test , appropriate . To assess data normality , Kolmogorov-Smirnov test perform data set . According preliminary study , 24 patient would require group power 0.9 type I error 0.05 . Factoring drop-out rate 10 % , investigator calculate 27 patient would require group . All statistical analysis perform SPSS 18.0 ( SPSS Inc. , Chicago , IL , USA ) program . A P value &lt; 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Atracurium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<criteria>American Society Anesthesiologists ( ASA ) physical status III BMI 2030 kg/m2 Patients schedule mastoidectomy tympanoplasty . history allergy study drug , neuromuscular disease , pregnancy breastfeeding , preoperative medication antipsychotic neuroleptic know interact NMBAs serum creatinine level &gt; 1.2 mg/dL , liver transaminase &gt; 40 U/L .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>combination</keyword>
	<keyword>rocuronium</keyword>
	<keyword>cisatracurium</keyword>
	<keyword>neuromuscular blockade monitoring</keyword>
	<keyword>drug synergism</keyword>
</DOC>